Stroke Trial, Recruiting NCT06514976 Sponsor: POLYSAN Scientific & Technological Pharmaceutical Company Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06514976
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You have been diagnosed with an ischemic stroke (a stroke caused by a blood clot blocking blood flow to the brain) that started within the last 36 hours
  • You have some measurable weakness or movement problems in your arms or legs as a result of the stroke, measured using a standard medical scale
  • Your doctors have decided to treat your stroke without using clot-busting drugs or procedures to remove the clot
  • You are planned to receive either a specific medication called Cytoflavin® for at least 10 days, another brain-protective medication for at least 10 days, or no brain-protective medication at all
  • You have signed a form agreeing to take part in the study

Who may not be able to join:

  • You are in a coma at the time of enrolling in the trial
  • Before your stroke, you already had significant disability that meant you needed help with everyday activities
  • You have a history of Parkinson's disease, dementia, multiple sclerosis, or other conditions that already affect your nervous system
  • You have a serious illness where doctors expect you may not live longer than 6 months
  • You are pregnant or breastfeeding
  • You have any other serious medical or mental health condition that could affect your ability to safely take part or to fully agree to participation (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
POLYSAN Scientific & Technological Pharmaceutical Company
Registry
ClinicalTrials.gov
Start date
1 March 2024
Est. completion
30 September 2025

Where this trial is recruiting

🇷🇺 Russia

Primary endpoints

Percentage of patients with favorable functional outcome (score 0-2) according to Modified Rankin Scale (mRS) on Day of Discharge (assessment at Visit 4 or Visit 5, on Day of Discharge) and on Day 90;

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov